Cardiac excellence again was the primary driver as Lankenau Medical Center, part of Main Line Health, received recognition as one of the 50 best hospitals in America in the nation in a Healthgrades survey.

Lankenau was recognized with the America’s 50 Best Hospitals for Cardiac Surgery Award™ as well as the America’s 100 Best Hospitals for Cardiac Care Award.™ It was the third straight year for the cardiac awards as well as the overall award. In addition, Lankenau received a Pulmonary Care Excellence Award.™

“Our focus is on Lankenau being a center for unmatched, cutting-edge care,” said Phillip Robinson, president, Lankenau Medical Center. “This honor validates the hard work and efforts of our team to give our patients the best treatment for their condition and personalized care. It is a credit to the cardiac leadership of William Gray, MD, and Basel Ramlawi, MD, FACC, and the entire group of cardiologists, cardiac surgeons, nurses, advanced practice providers, technologists and staff members.”

The award for cardiac surgery recognizes superior clinical outcomes in heart bypass and valve surgery. The award for cardiac care is based on superior clinical outcomes in coronary interventional procedures, heart attack treatment and heart failure treatment in addition to bypass and valve surgery.

The efforts of the cardiac and pulmonary teams were critical to Lankenau’s ranking by Healthgrades as one of the 50 best hospitals overall, placing it among the top 1% of all centers across the country. It is one of only four hospitals in Pennsylvania to receive that distinction.

Lankenau Heart Institute is the comprehensive cardiovascular medicine and surgery program comprising Main Line Health’s four acute-care hospitals—Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital and Riddle Hospital.

Lankenau Heart Institute is transforming the field of cardiovascular care by expanding the use of minimally invasive and transcatheter-based therapies. It offers one of the largest portfolios of minimally invasive valve repair options.

Lankenau Heart Institute is one of the few sites in the nation to conduct first-in-human clinical research through the Food and Drug Administration’s novel Early Feasibility Studies program.

The Lankenau Heart Institute is Main Line Health's premier, comprehensive cardiovascular medicine and surgery program. Lankenau Heart Institute brings together the clinical expertise of all four Main Line Health acute care hospitals and community cardiology practices to ensure that patients receive a level of quality, service, and experience that is unprecedented in the region. Through the system-wide coordination of services, Lankenau Heart Institute delivers preventive, diagnostic, therapeutic, and rehabilitative cardiovascular services at each of our locations including Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital and Riddle Hospital.

Lankenau Heart Institute continues to be an innovator in the use of beating-heart techniques and robotic-assisted procedures for coronary artery revascularization, minimally invasive and transcatheter approaches for valve repair and replacement, complex aortic surgery and heart rhythm disorders. With our growing experience and focus on minimally invasive techniques, Lankenau Heart Institute has expanded participation in clinical trials year over year. Our physicians are frequently invited to participate in clinical/medical device trials, many of these designed to facilitate and expand the use of minimally invasive approaches and procedures.

With a collaborative team of expert consultative cardiologists, interventional cardiologists, electrophysiologists, cardiovascular surgeons and specially trained advance practice nurses and technologists, Lankenau Heart Institute is dedicated to managing and treating patients with simple to complex cardiovascular disease, including heart failure, aortic disease, coronary and peripheral vascular disease, heart rhythm disorders and valve disease. Our team of cardiologists and cardiac specialists provide patients and their families with expert cardiac care, close to home.

Lankenau Medical Center, a member of Main Line Health, has been devoted to the health and well-being of the community since 1860, with a founding mission to serve all those in need. Our continued dedication to service, compassionate patient care and superior clinical programs makes Lankenau a preferred destination for care by people throughout the Philadelphia region and beyond. Lankenau offers primary care, disease prevention and specialized medical and surgical management of all diseases and disorders, as well as access to clinical trials. As a 371-bed teaching and research hospital, Lankenau is committed to maintaining high-level expertise across all clinical areas and is consistently recognized for providing outstanding care. Lankenau is ranked in U.S. News & World Report's Best Hospitals 2022–23 in the top three in the Philadelphia region, top six in Pennsylvania and top 50 in the nation for obstetrics and gynecology. Lankenau is rated as high performing in the following specialties: Cardiology & Heart Surgery, Orthopedics, Pulmonology & Lung Surgery, Urology. Lankenau is rated as high-performing in the following procedures and conditions: Aortic Valve Surgery, Back Surgery (spinal fusion), Chronic Obstructive Pulmonary Disease (COPD), Colon Cancer Surgery, Diabetes, Heart Attack, Heart Bypass Surgery, Heart Failure, Hip Fracture, Hip Replacement, Knee Replacement, Kidney Failure, Lung Cancer Surgery, Pneumonia, Transcatheter Aortic Valve Replacement (TAVR). Lankenau has achieved The Joint Commission's Gold Seal of Approval for stroke care and breast cancer care and is one of the nation's Top Performing Hospitals for heart attack, heart failure, pneumonia and surgical care. Lankenau Medical Center was rated a top performer in the Centers for Medicare & Medicaid Services' (CMS) Overall Hospital Quality Star Rating. Lankenau has also earned the highest distinction for excellence in nursing care, the American Nurses Credentialing Center Magnet® designation.

Founded in 1985, Main Line Health is a not-for-profit health system serving Philadelphia and its suburbs. Main Line Health's commitment—to deliver advanced medicine for treating and curing disease, playing an important role in prevention and disease management as well as training physicians and other health care providers—reflects our intent to be the region's premier choice for clinical care, research, and education. A team of nearly 13,000 employees and more than 2,000 physicians care for patients throughout the Main Line Health System.

At Main Line Health's core are four of the region's most respected acute care hospitals—Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital and Riddle Hospital—as well as one of the nation's premier facilities for rehabilitative medicine, Bryn Mawr Rehabilitation Hospital.

Main Line Health also includes Mirmont Treatment Center for drug and alcohol recovery; Main Line Health HomeCare & Hospice, which includes skilled home health care, hospice and home infusion services; Main Line Health Centers, primary and specialty care, lab and radiology, and other outpatient services located in Broomall, Collegeville, Concordville, Exton, King of Prussia and Newtown Square; Lankenau Institute for Medical Research, a biomedical research organization; and Main Line HealthCare, one of the region's largest multispecialty physician networks.

For more information, visit mainlinehealth.org and connect with us on social media:

LinkedIn: www.linkedin.com/company/main-line-health
Facebook: www.facebook.com/mainlinehealth
Twitter: www.twitter.com/mainlinehealth
Instagram: www.instagram.com/mainlinehealth